Cotrimoxazole Prophylaxis Discontinuation among Antiretroviral-Treated HIV-1-Infected Adults in Kenya: A Randomized Non-inferiority Trial

BACKGROUND: Cotrimoxazole (CTX) prophylaxis is recommended by the World Health Organization (WHO) for HIV-1-infected individuals in settings with high infectious disease prevalence. The WHO 2006 guidelines were developed prior to the scale-up of antiretroviral therapy (ART). The threshold for CTX di...

Full description

Saved in:
Bibliographic Details
Published in:PLoS Med
Main Authors: Polyak, Christina S., Yuhas, Krista, Singa, Benson, Khaemba, Monica, Walson, Judd, Richardson, Barbra A., John-Stewart, Grace
Format: Artigo
Language:Inglês
Published: Public Library of Science 2016
Subjects:
Research Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4701407/
https://ncbi.nlm.nih.gov/pubmed/26731191
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pmed.1001934
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items